Lipoarabinomannan-based tuberculosis diagnosis using a fiber cavity ring down biosensor.

Despite existing for millennia, tuberculosis (TB) remains a persistent global health challenge. A significant obstacle in controlling TB spread is the need for a rapid, portable, sensitive, and accurate diagnostic test. Currently, sputum culture stands as a benchmark test for TB diagnosis. Although highly reliable, it necessitates advanced laboratory facilities and involves considerable testing time. In this context, we present a rapid, portable, and cost-effective optical fiber sensor designed to measure lipoarabinomannan (LAM), a TB biomarker found in patients' urine samples. Our sensing approach is based on the applications of phase shift-cavity ringdown spectroscopy (PS-CRDS) to an optical fiber cavity created by two fiber Bragg gratings. A tapered fiber is spliced inside the optical cavity to serve as the sensing head. We functionalize the tapered fiber surface with anti-LAM antigen CS-35 through a unique chemistry, creating a strong affinity for LAM molecules. We measure the phase difference between the cavity transmission and the reference modulating signal at the cavity output. The measured phase is directly proportional to the injected LAM concentrations in aqueous solutions over the sensing head. Our demonstrated sensor provides a detection limit of 10 pg/mL and a sensitivity of 0.026°/pg/mL. This sensor holds promise for numerous applications in the healthcare sector, particularly in low-resource settings.

Reduction-Sensitive Dextran-Paclitaxel Polymer-Drug Conjugate: Synthesis, Self-Assembly into Nanoparticles, and In Vitro Anticancer Efficacy.

Delivery systems that can encapsulate a precise amount of drug and offer a spatiotemporally controlled drug release are being actively sought for safe yet effective cancer therapy. Compared to polymer nanoparticle (NP)-based delivery systems that rely on physical drug encapsulation, NPs derived from stimuli-sensitive covalent polymer-drug conjugates (PDCs) have emerged as promising alternatives offering precise control over drug dosage and spatiotemporal drug release. Herein, we report a reduction-sensitive PDC "Dex-SS-PTXL" synthesized by conjugating dextran and paclitaxel (PTXL) through a disulfide bond-bearing linker. The synthesized Dex-SS-PTXL PDC with a precise degree of substitution in terms of the percentage of repeat units of dextran covalently conjugated to PTXL (27 ± 0.6%) and the amount of drug carried by the PDC (39 ± 1.4 wt %) was found to self-assemble into spherical NPs with an average size of 110 ± 34 nm and a ζ-potential of -14.09 ± 8 mV. The reduction-sensitive Dex-SS-PTXL NPs were found to release PTXL exclusively in response to the reducing agent concentration reflective of the intracellular reducing environment of the tumor cells. Challenging BT-549 and MCF-7 cells with Dex-SS-PTXL NPs revealed significant cytotoxicity, while the IC50 values and the mode of action (mitotic arrest) of Dex-SS-PTXL NPs were found to be comparable to those of free PTXL, highlighting the active nature of the intracellularly released drug. The developed PDC with its unique ability to self-assemble into NPs and stimuli-responsive drug release can enhance the success of the NP-based drug delivery systems during clinical translation.

Reversible Diels-Alder and Michael Addition Reactions Enable the Facile Postsynthetic Modification of Metal-Organic Frameworks.

Functionalization of metal-organic frameworks (MOFs) is critical in exploring their structural and chemical diversity for numerous potential applications. Herein, we report multiple approaches for the tandem postsynthetic modification (PSM) of various MOFs derived from Zr(IV), Al(III), and Zn(II). Our current work is based on our efforts to develop a wide range of MOF platforms with a dynamic functional nature that can be chemically switched via thermally triggered reversible Diels-Alder (DA) and hetero-Diels-Alder (HDA) ligations. Furan-tagged MOFs (furan-UiO-66-Zr) were conjugated with maleimide groups bearing dienophiles to prepare MOFs with a chemically switchable nature. As HDA pairs, phosphoryl dithioester-based moieties and cyclopentadiene (Cp)-grafted MOF (Cp-MIL-53-Al) were utilized to demonstrate the cleavage and rebonding of the linkages as a function of temperature. In addition to these strategies, the Michael addition reaction was also applied for the tandem PSM of IRMOF-3-Zn. Maleimide groups were postsynthetically introduced in the MOF lattice, which were further ligated with cysteine-based biomolecules via the thiol-maleimide Michael addition reaction. On the basis of the versatility of the herein presented chemistry, we expect that these approaches will help in designing a variety of sophisticated functional MOF materials addressing diverse applications.

Binding enhancements of antibody functionalized natural and synthetic fibers.

Development of low cost biosensing using convenient and environmentally benign materials is important for wide adoption and ultimately improved healthcare and sustainable development. Immobilized antibodies are often incorporated as an essential biorecognition element in point-of-care biosensors but these proteins are costly. We present a strategy of combining convenient and low-cost surface functionalization approaches for increasing the overall binding activity of antibody functionalized natural and synthetic fibers. We demonstrate a simple one-step in situ silica NP growth protocol for increasing the surface area available for functionalization on cotton and polyester fabrics as well as on nanoporous cellulose substrates. Comparing this effect with the widely adopted and low cost plant-based polyphenol coating to enhance antibody immobilization, we find that both approaches can similarly increase overall surface activity, and we illustrate conditions under which the two approaches can produce an additive effect. Furthermore, we introduce co-immobilization of antibodies with a sacrificial "steric helper" protein for further enhancing surface activities. In combination, several hundred percent higher activities compared to physical adsorption can be achieved while maintaining a low amount of antibodies used, thus paving a practical path towards low cost biosensing.

Colon specific enzyme responsive oligoester crosslinked dextran nanoparticles for controlled release of 5-fluorouracil.

Targeting bioactives selectively to diseased sites is one of the most challenging aspects of cancer therapy. Herein, fabrication of colonic enzyme-responsive dextran based oligoester crosslinked nanoparticles is reported for the controlled release of 5-fluorouracil (5-FU) - an anticancer drug. The 5-FU drug loaded nanoparticles (DNPs, size ~237 ± 25 nm, ζ-potential -17.0 ± 3 mV) were developed by the in-situ crosslinking of dextran with a bifunctional telechelic oligoester followed by the physical drug encapsulation via nanoprecipitation. Drug encapsulation efficiency and drug loading capacity of DNPs were found to be ~76% (±0.1) and ~8% (±0.1), respectively. The DNPs were demonstrated to release the encapsulated drug selectively in the presence of dextranase enzyme. The in vitro release kinetics assay revealed that the DNPs released about 75% (±4) of the entrapped drug within 12 h of incubation with dextranase enzyme. No drug was released in a control experiment where DNPs were exposed to pH conditions encountered in the stomach and small intestine. Moreover, the treatment of HCT116 colon cancer cell line with the developed DNPs highlighted its biocompatibility as well as dextranase triggered cytotoxicity. The developed system offers an avenue to reduce the non-specific cytotoxicity of the encapsulated 5-FU, and a colon specific delivery of the encapsulated drug in response to the dextranase enzyme.

Utilization of Biomass Fly Ash for Improving Quality of Organic Dye-Contaminated Water.

Development of innovative methodologies to convert biomass ash into useful materials is essential to sustain the growing use of biomass for energy production. Herein, a simple chemical modification approach is employed to functionalize biomass fly ash (BFA) with 3-aminopropyltriethoxy silane (APTES) to develop an inexpensive and efficient adsorbent for water remediation. The amine-functionalized BFA (BFA-APTES) was fully characterized by employing a range of characterization techniques. Adsorption behavior of BFA-APTES was evaluated against two anionic dyes, namely, alizarin red S (ARS) and bromothymol blue (BTB). In the course of experimental data analysis, the computation tools of data fitting for linear and nonlinear form of Langmuir, Freundlich, and the modified Langmuir-Freundlich adsorption isotherms were used with the aid of Matlab R2019b. In order to highlight the misuse of linearization of adsorption models, the sum of the squares of residues (SSE) values obtained from nonlinear models are compared with R 2 values obtained from the linear regression. The accuracy of the data fitting was checked by the use of SSE as an error function instead of the coefficient of determination, R 2. The dye adsorption capacity of BFA-APTES was also compared with the nonfunctionalized BFA. The maximum adsorption capacities of BFA-APTES for ARS and BTB dye molecules were calculated to be around 13.42 and 15.44 mg/g, respectively. This value is approximately 2-3 times higher than the pristine BFA. A reasonable agreement between the calculated and experimental values of q e obtained from the nonlinear form of kinetic models verified the importance of using equations in their original form. The experimentally calculated thermodynamic parameters including molar standard Gibbs free energy (Δad G m 0) and molar standard enthalpy change (Δad H m 0) reflected that the process of adsorption of dye molecules on the BFA-APTES adsorbent was spontaneous and exothermic in nature. Moreover, the used BFA-APTES adsorbent could be regenerated and reused for several cycles with significant dye adsorption capacity. The remediation capability of the BFA-APTES adsorbent against ARS dye was also demonstrated by packing a small column filled with the BFA-APTES adsorbent and passing a solution of ARS through it. Overall, we provide a simple and scalable route to convert BFA into an efficient adsorbent for water remediation applications.

Nanoporous thin films in optical waveguide spectroscopy for chemical analytics.

Spectroscopy with planar optical waveguides is still an active field of research for the quantitative analysis of various supramolecular surface architectures and processes, and for applications in integrated optical chip communication, direct chemical sensing, etc. In this contribution, we summarize some recent development in optical waveguide spectroscopy using nanoporous thin films as the planar substrates that can guide the light just as well as bulk thin films. This is because the nanoporosity is at a spacial length-scale that is far below the wavelength of the guided light; hence, it does not lead to an enhanced scattering or additional losses of the optical guided modes. The pores have mainly two effects: they generate an enormous inner surface (up to a factor of 100 higher than the mere geometric dimensions of the planar substrate) and they allow for the exchange of material and charges between the two sides of the solid thin film. We demonstrate this for several different scenarios including anodized aluminum oxide layers for the ultrasensitive determination of the refractive index of fluids, or the label-free detection of small analytes binding from the pore inner volume to receptors immobilized on the pore surface. Using a thin film of Ti metal for the anodization results in a nanotube array offering an even further enhanced inner surface and the possibility to apply electrical potentials via the resulting TiO2 semiconducting waveguide structure. Nanoporous substrates fabricated from SiNx thin films by colloid lithography, or made from SiO2 by e-beam lithography, will be presented as examples where the porosity is used to allow for the passage of ions in the case of tethered lipid bilayer membranes fused on top of the light-guiding layer, or the transport of protons through membranes used in fuel cell applications. The final example that we present concerns the replication of the nanopore structure by polymers in a process that leads to a nanorod array that is equally well suited to guide the light as the mold; however, it opens a totally new field for integrated optics formats for direct chemical and biomedical sensing with an extension to even molecularly imprinted structures. Graphical abstract.

Controlled release of cephradine by biopolymers based target specific crosslinked hydrogels.

The novel silane crosslinked (TEOS) hydrogels based on eco-friendly biodegradable chitosan/guargum were prepared by blending with PEG to develop pH sensitive hydrogels (CGP) and achieved its hydrophilicity and target specificity for controlled release of drug. The crosslinker amount was varied to analyze its effect on the hydrogel properties and were characterized using FTIR, SEM, TGA, swelling studies (water, buffer and ionic solution) and in-vitro release of cephradine (CED). FTIR confirmed the presence of characteristic peaks and crosslinking between the components while SEM images showed the formation of clear micro- and macro-pores. The swelling behavior in water showed that compared to the controlled hydrogel, the crosslinked hydrogels revealed more swelling but a decrease in swelling with further increase in the amount of crosslinker was observed. The hydrogels showed low swelling at basic and neutral pH while maximum swelling was observed at acidic pH. This pH response made these hydrogels an ideal candidate for injectable controlled release. The CED was loaded on hydrogels and its release mechanism was studied in PBS, SGF and SIF which revealed that out of all hydrogels (CGP100, CGP150, CGP200 and CGP250), CGP100 has shown CED release of 85% in 130 min in PBS and 82.4% in SIF.

Silica based inorganic-organic hybrid materials for the adsorptive removal of chromium.

We employed polymer functionalized silica gel as an adsorbent for the removal of Cr(vi) from water. The chains of 2-aminoethyl methacrylate hydrochloride (AEMA·HCl) polymer were grown from the surface of silica gel via surface-initiated conventional radical polymerization and the resulting hybrid material exhibited high affinity for chromium(vi). To investigate the adsorption behavior of Cr(vi) on diverse polymer based hybrid materials, the removal capacity of (SG-AEMH) was compared with our previously reported branched polyamine functionalized mesoporous silica (MS-PEI). The adsorption capacities of polymer based materials were also compared with their respective monolayer based platforms comprising a 3-aminopropyltriethoxysilane (APTES) functionalized silica gel (SG-APTES) and mesoporous silica (MS-APTES). The polymer based systems showed excellent Cr(vi) adsorption efficiencies compared to monolayer counterparts. The structural characteristics and surface modification of these adsorbents were examined by Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), and thermogravimetric analysis (TGA). The experimental data were analyzed using the Langmuir and Freundlich models. Correlation coefficients were determined by analyzing each isotherm. The kinetic data of adsorption reactions were described by pseudo-first-order and pseudo-second-order equations. Thermodynamic parameters, i.e., change in the free energy (ΔG°), the enthalpy (ΔH°), and the entropy (ΔS°), were also evaluated. The synthesized hybrid materials exhibited a high adsorption capacity for chromium ions. Furthermore, they could be regenerated and recycled effectively.

Chemically reprogrammable metal organic frameworks (MOFs) based on Diels-Alder chemistry.

We present the reversible Diels-Alder functionalization of metal organic frameworks (MOFs). Cyclopentadiene (Cp) functional MOFs are ligated with dienophiles to fabricate functional MOFs with a reprogrammable chemical nature. Our strategy thus constitutes an unprecedented concept for chemically dynamic MOFs able to be recoded.

Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles.

PEGylated nanoparticles have been extensively investigated in different platforms for drug delivery. However, the physiological effects related to platelet activation, and the potential procoagulant activity which could lead to thrombosis and further cardiovascular diseases have not been widely examined. In this work, we studied the effect of differentially charged PEGylated lipid-polymer nanoparticles in the human platelet aggregation and activation by light transmission aggregometry and flow cytometry. PEGylated nanoparticles inhibited the platelet aggregation with a dose dependency (350, 700, and 1400µg/mL) in both ADP- and collagen-induced platelet aggregation, and P-selectin expression. Charged nanoparticles (anionic and cationic) presented higher inhibitions of the platelet aggregation compared to neutral nanoparticles, and particularly the cationic particles generated a slightly higher effect. The obtained results demonstrated the safety of the differentially charged PEGylated lipid-polymer nanoparticles, and their ability to inhibit the aggregation and activation of human platelets stimulated by two classic platelet activators.

Targeted brain delivery nanoparticles for malignant gliomas.

Brain tumors display the highest mortality rates of all childhood cancers, and over the last decade its prevalence has steadily increased in elderly. To date, effective treatments for brain tumors and particularly for malignant gliomas remain a challenge mainly due to the low permeability and high selectivity of the blood-brain barrier (BBB) to conventional anticancer drugs. In recent years, the elucidation of the cellular mechanisms involved in the transport of substances into the brain has boosted the development of therapeutic-targeted nanoparticles (NPs) with the ability to cross the BBB. Here, we present a comprehensive overview of the available therapeutic strategies developed against malignant gliomas based on 'actively targeted' NPs, the challenges of crossing the BBB and blood-brain tumor barrier as well as its mechanisms and a critical assessment of clinical studies that have used targeted NPs for the treatment of malignant gliomas. Finally, we discuss the potential of actively targeted NP-based strategies in clinical settings, its possible side effects and future directions for therapeutic applications. First draft submitted: 4 October 2016; Accepted for publication: 14 October 2016; Published online: 23 November 2016.

Encapsulation of Antibiotic Levofloxacin in Biocompatible Microemulsion Formulation: Insights from Microstructure Analysis.

Microemulsions (µEs) are unique systems that offer exciting perspectives in biophysical research for mimicing biomembranes at the molecular level. In the present study, biocompatible µE formulation of a new oil-in-water (o/w) system comprising clove oil/Tween 20/2-propanol/water was accomplished for encapsulating an antibiotic, levofloxacin (LVF). The pseudoternary phase diagram was delineated at a constant cosurfactant/surfactant (2:1) ratio to meet the economic feasibility. The gradual changes occurring in the microstructure of the as-formulated four-component µEs were explored via multiple complementary characterization techniques. The results of electrical conductivity (σ), viscosity (η), and optical microscopic measurements suggested the existence of a percolation transition to a bicontinuous structure in the microregions of the as-formulated µE. LVF displayed a high solubility (5.0 wt %) at the pH of 6.9 in an optimum µE formulation comprising 2-propanol (36.4%), Tween 20 (18.2%), clove oil (20.7%), and water (24.7%). The LVF-loaded µE composition showed long-term stability for over 6 months of storage. Fourier transform IR analysis showed that LVF was stable inside the µE formulation, indicating the absence of any possible aggregation of LVF. Dynamic light scattering revealed that the average particle size of drug-free µE (64.5 ± 3.4 nm) increases to 129.7 ± 5.8 nm upon loading of LVF, suggesting the accumulation of LVF in the interfacial layers of the micelles. Moreover, fluorescence measurements indicated that LVF might be localized in the interfacial film of µE system, which may result in a controlled release of drug.

Temperature-driven self-assembly of self-limiting uniform supraparticles from non-uniform unimolecular micelles.

In this work, the self-assembly of non-uniform unimolecular micelles constituted of a hyperbranched polyester core decorated with a corona of thermoresponsive poly(N-isopropylacrylamide) (PNIPAm) chains has been studied. As revealed by dynamic light scattering (DLS), transmission electron microscopy (TEM) and small angle X-ray scattering (SAXS), these unimicelles form uniform supraparticles through a thermally-induced self-limited process, as well as exhibit molecular features commonly observed in PNIPAm-based gels. We believe that these results provide new insights into the application of stimuli-responsive polymeric materials as versatile building blocks to build up soft supraparticles displaying well-defined dimensional characteristics.

Drug Delivery Nanocarriers from a Fully Degradable PEG-Conjugated Polyester with a Reduction-Responsive Backbone.

The remarkably high intracellular concentration of reducing agents is an excellent endogenous stimulus for designing nanocarriers programmed for intracellular delivery of therapeutic agents. However, despite their excellent biodegradability profiles, aliphatic polyesters that are fully degradable in response to the intracellular reducing environment are rare. Herein, a reduction-responsive drug delivery nanocarrier derived from a linear polyester bearing disulfide bonds is reported. The reduction-responsive polyester is synthesized via a convenient polycondensation process. After conjugation of terminal carboxylic acid groups of polyester to polyethylene glycol (PEG), the resulting polymer self-assembles into nanoparticles that are capable of encapsulating dye and anticancer drug molecules. The reduction-responsive nanoparticles display a fast payload release rate in response to the intracellular reducing environment, which translates into superior anticancer activity towards PC-3 cells.

Hydrophobic Cysteine Poly(disulfide)-based Redox-Hypersensitive Nanoparticle Platform for Cancer Theranostics.

Selective tumor targeting and drug delivery are critical for cancer treatment. Stimulus-sensitive nanoparticle (NP) systems have been designed to specifically respond to significant abnormalities in the tumor microenvironment, which could dramatically improve therapeutic performance in terms of enhanced efficiency, targetability, and reduced side-effects. We report the development of a novel L-cysteine-based poly (disulfide amide) (Cys-PDSA) family for fabricating redox-triggered NPs, with high hydrophobic drug loading capacity (up to 25 wt% docetaxel) and tunable properties. The polymers are synthesized through one-step rapid polycondensation of two nontoxic building blocks: L-cystine ester and versatile fatty diacids, which make the polymer redox responsive and give it a tunable polymer structure, respectively. Alterations to the diacid structure could rationally tune the physicochemical properties of the polymers and the corresponding NPs, leading to the control of NP size, hydrophobicity, degradation rate, redox response, and secondary self-assembly after NP reductive dissociation. In vitro and in vivo results demonstrate these NPs' excellent biocompatibility, high selectivity of redox-triggered drug release, and significant anticancer performance. This system provides a promising strategy for advanced anticancer theranostic applications.

Photolithographic patterning of 3D-formed polycarbonate films for targeted cell guiding.

A facile photolithographic platform for the design of cell-guiding polymeric substrates is introduced. Specific areas of the substrate are photo-deactivated for the subsequent growth of bioresistant polymer brushes, creating zones for cell proliferation, and protein adhesion.

A solvent-free thermosponge nanoparticle platform for efficient delivery of labile proteins.

Protein therapeutics have gained attention recently for treatment of a myriad of human diseases due to their high potency and unique mechanisms of action. We present the development of a novel polymeric thermosponge nanoparticle for efficient delivery of labile proteins using a solvent-free polymer thermo-expansion mechanism with clinical potential, capable of effectively delivering a range of therapeutic proteins in a sustained manner with no loss of bioactivity, with improved biological half-lives and efficacy in vivo.

Insight into nanoparticle cellular uptake and intracellular targeting.

Collaborative efforts from the fields of biology, materials science, and engineering are leading to exciting progress in the development of nanomedicines. Since the targets of many therapeutic agents are localized in subcellular compartments, modulation of nanoparticle-cell interactions for efficient cellular uptake through the plasma membrane and the development of nanomedicines for precise delivery to subcellular compartments remain formidable challenges. Cellular internalization routes determine the post-internalization fate and intracellular localization of nanoparticles. This review highlights the cellular uptake routes most relevant to the field of non-targeted nanomedicine and presents an account of ligand-targeted nanoparticles for receptor-mediated cellular internalization as a strategy for modulating the cellular uptake of nanoparticles. Ligand-targeted nanoparticles have been the main impetus behind the progress of nanomedicines towards the clinic. This strategy has already resulted in remarkable progress towards effective oral delivery of nanomedicines that can overcome the intestinal epithelial barrier. A detailed overview of the recent developments in subcellular targeting as a novel platform for next-generation organelle-specific nanomedicines is also provided. Each section of the review includes prospects, potential, and concrete expectations from the field of targeted nanomedicines and strategies to meet those expectations.